LONDON--(BUSINESS WIRE)--Virion Biotherapeutics announced today the appointments of Vanessa King, PhD, as President & Chief Executive Officer and Isabel Najera, PhD, as Chief Scientific Officer.

PHILADELPHIA, Oct. 26, 2023 /PRNewswire/ -- Virion Therapeutics, LLC, a clinical-stage biotechnology company developing novel T cell-based immunotherapies, and its Joint Venture partner, Ocean ...

Providence, RI, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the development of compelling discoveries from top research ...

KING OF PRUSSIA, Pa., Feb. 22, 2023 /PRNewswire/ -- Center for Breakthrough Medicines (CBM), a contract development and manufacturing organization (CDMO) dedicated to addressing critical challenges ...

VIENNA, June 21, 2023 /PRNewswire/ -- Virion Therapeutics, LLC, a clinical stage company developing T cell-based immunotherapies for cancer and chronic infectious diseases, today, presented data ...

Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, No. 26 (Dec. 18, 2001), pp. 14877-14882 (6 pages) The envelope proteins (env) of simian immunodeficiency virus ...

Researchers at Semmelweis University and the National Public Health Center in Hungary have conducted an imaging study showing that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the ...

Yellow Fever virus is among the most dangerous pathogens circulating today. As many as half of hospitalized patients succumb to disease complications. The disease typically impacts tropical climates, ...

The Centers for Disease Control and Prevention has issued a Level 3 travel advisory for Rwanda due to an outbreak of the Marburg virus. Marburg virus disease, or MVD, is a serious, often fatal disease ...

A team of scientists of the University of Chicago and the University of California San Diego has developed a coarse-grained (CG) model of the severe acute respiratory syndrome coronavirus 2 ...